Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, United States; Department of Immunology, Harvard Medical School, Boston, MA, United States.
Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, United States; Department of Immunology, Harvard Medical School, Boston, MA, United States.
Adv Immunol. 2018;140:1-20. doi: 10.1016/bs.ai.2018.09.001. Epub 2018 Oct 9.
Regulatory T cells are central mediators of immune regulation and play an essential role in the maintenance of immune homeostasis in the steady state and under pathophysiological conditions. Disruption of CD8 Treg-dependent recognition of Qa-1-restricted self-antigens can result in dysregulated immune responses, tissue damage, autoimmune disease and cancer. Recent progress in studies on regulatory T cells of the CD8 lineage has provided new biological insight into this specialized regulatory T cell subpopulation. Identification of the Helios transcription factor as an essential control element for the differentiation and function of CD8 regulatory T cells has led to a better understanding of the unique genetic program of these cells. Recent analyses of T-cell receptor usage and antigen recognition by Qa-1-restricted CD8 Treg have provided additional insight into the unusual biological function of this regulatory CD8 lineage. Here we summarize recent advances in our understanding of CD8 regulatory T cells with emphasis on lineage commitment, differentiation and stability.
调节性 T 细胞是免疫调节的中枢介质,在稳态和病理生理条件下维持免疫稳态中发挥着重要作用。CD8 Treg 对 Qa-1 限制自身抗原的识别障碍可导致免疫反应失调、组织损伤、自身免疫性疾病和癌症。CD8 谱系调节性 T 细胞研究的最新进展为这一特殊调节性 T 细胞亚群提供了新的生物学见解。鉴定 Helios 转录因子作为 CD8 调节性 T 细胞分化和功能的必需控制元件,有助于更好地理解这些细胞的独特遗传程序。最近对 Qa-1 限制的 CD8 Treg 的 T 细胞受体使用和抗原识别的分析提供了对这种调节性 CD8 谱系的异常生物学功能的更多了解。在这里,我们总结了我们对 CD8 调节性 T 细胞的最新理解,重点介绍了谱系决定、分化和稳定性。